Medplus Health Services' subsidiary, Optival Health Solutions, faced a three-day drug license suspension at a store by the Drugs Control Administration, impacting operations by ₹0.01 Crore.
Value
₹0.01 Cr
From
Drugs Control Administration, Haveri Circle, Karnataka
MedPlus Health Services' subsidiary, Optival Health Solutions, received a one-day drug license suspension from the Drugs Control Administration for a store in Telangana due to non-compliance.
Medplus Health Services' subsidiary, Optival Health, received a 7-day drug license suspension in Andhra Pradesh and stay orders for previous suspensions in Maharashtra.
Medplus Health Services disclosed that regulatory authorities suspended the drug licenses of five subsidiary stores for 3 to 7 days. The expected financial impact is ₹0.10 Crore.
Medplus Health Services reported a 7-day drug license suspension for a subsidiary store, impacting its operations with an estimated financial loss of ₹0.02 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced drug license suspensions for two stores from regulatory authorities, causing a total financial impact of Rs 0.0961 Crore.
Medplus Health Services reported a 5-day suspension of a drug license at a Mangalore store due to compliance issues. The expected financial impact is ₹0.03 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced a five-day drug license suspension at its Kapikad store due to regulatory violations. The impact is Rs 0.03 Crore.
MedPlus Health Services has filed board comments regarding a fine levied by the exchanges for non-compliance with Regulation 17(1A) of SEBI LODR Regulations, 2015.
Medplus approved acquiring the 0.01% residual stake in material subsidiary Optival Health Solutions for Rs.1.10 Crore. Optival's FY26 turnover of Rs.6,816 Crore will now be fully consolidated.
Medplus Health's subsidiary faces temporary drug license suspensions at two store locations in Bangalore and Pune, resulting in an estimated financial impact of Rs 0.15 Crore.
Alka Ajit Rangnekar, an immediate relative of a director, acquired 3,725 equity shares via off-market transfer. The transaction value amounts to approximately ₹0.24 Crore.
The Drugs Control Administration suspended the drug license of Medplus's subsidiary, Optival Health Solutions, for five days. The financial impact of this suspension is ₹0.02 Crore.
Medplus Health reported temporary drug license suspensions at three pharmacy stores, with a financial impact of ₹0.07 Crore. A prior suspension in Pune was stayed.
Medplus Health Services reported 7-day drug license suspensions for four stores across three states. The estimated financial impact of these operational disruptions is ₹0.09 Crore.
Medplus Health Services reported drug license suspensions for three of its subsidiary's stores due to regulatory violations, with an estimated financial impact of ₹0.06 Crore.
Catalyst Trusteeship Limited filed a SAST Reg 29(1) disclosure regarding the creation of a pledge on 62,51,066 equity shares of MedPlus Health Services Limited.
MedPlus Health Services Limited held its 20th Annual General Meeting on August 17, 2026, via video conferencing to transact ordinary and special business.
Medplus Health Services' subsidiary, Optival Health Solutions, received a 2-day drug license suspension at a specific store for minor regulatory non-compliance.
Medplus Health Services' subsidiary, Optival Health Solutions, faces temporary drug license suspensions for four stores in Karnataka due to regulatory non-compliance.
MedPlus Health Services reported a 7-day drug license suspension for a subsidiary store in Andhra Pradesh due to regulatory non-compliance. The financial impact is ₹0.03 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faces temporary drug license suspensions for two stores. The estimated financial impact is Rs 0.03 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced a two-day drug license suspension at a Karnataka store. The regulatory action impacts operations by Rs 0.0071 Crore.
MedPlus's subsidiary, Optival Health Solutions, received a two-day drug license suspension for a store in Karnataka. The potential revenue impact is Rs 0.0071 Crore.
